Freed's co-founder & CEO Erez Druk and his physician-wife, Gabi Meckler. (Photo: Business Wire)

Freed Secures $30M Series A Led by Sequoia Capital to Free Clinicians from Administrative Burdens with AI Assistant

This latest round of funding fuels Freed’s rapid expansion beyond AI note writing, building a next-generation AI clinician assistant as the company surpasses 17,000 paying clinicians Press Release – March 05, 2025 – SAN FRANCISCO – Freed, an AI clinician assistant designed to reduce the burdens of medical documentation, today announced it has raised $30 million in Series A funding, led by Sequoia Capital with … Continue reading Freed Secures $30M Series A Led by Sequoia Capital to Free Clinicians from Administrative Burdens with AI Assistant

Philips advances imaging innovation with remote scanning capabilities across Europe

Philips advances imaging innovation with remote scanning capabilities across Europe

News Release – Feb 25, 2025 Vendor-agnostic, multi-modality Radiology Operations Command Center connects technologists, radiologists, and imaging experts in real time EU Medical Device Regulation certified remote scanning capability helps to improve the operation of radiology workflows Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Philips Radiology Operations Command Center Console has received its EU Medical Device Regulation … Continue reading Philips advances imaging innovation with remote scanning capabilities across Europe

Kamel Ghribi

Kamel Ghribi Impact Pioneer in Health Innovation & Infrastructure

Distinguished entrepreneur and visionary, Kamel Ghribi, has significantly transformed healthcare delivery across the Middle East through his pioneering smart clinics. As the Chairman of GKSD Healthcare, Ghribi has seamlessly integrated innovative healthcare solutions with sustainable practices, setting a new benchmark in the region. The Success of Smart Clinics in the Middle East Under Ghribi’s leadership, GKSD Healthcare has expanded its footprint across the Middle East … Continue reading Kamel Ghribi Impact Pioneer in Health Innovation & Infrastructure

JOHNSON & JOHNSON

Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.

Acquisition includes CAPLYTA® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and monotherapy; also approved for the treatment of schizophrenia in adults sNDA submitted to U.S. FDA for CAPLYTA® as adjunctive treatment for major depressive disorder; if approved, CAPLYTA® has potential to become a standard of care for most common depressive disorders CAPLYTA® adds to Johnson & Johnson’s robust lineup of … Continue reading Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.

American Cancer Society

American Cancer Society BrightEdge Annual Report Reveals Impact of $43 Million Deployed to Advance Innovation and Healthcare Access

Oct 28, 2024 – ACS Impact Venture Fund (AIVF)’s active portfolio of 16 companies is transforming the fight against cancer through impact investing BOSTON, Oct. 28, 2024 – BrightEdge LLC, the American Cancer Society’s (ACS) venture capital and impact investment arm, has published its most recent annual report highlighting progress in the fight to end cancer as we know it. Since inception through EOY 2023, BrightEdge has invested … Continue reading American Cancer Society BrightEdge Annual Report Reveals Impact of $43 Million Deployed to Advance Innovation and Healthcare Access